Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1990 1
1991 1
1992 1
1993 1
1994 4
1995 1
1996 2
1997 2
1998 1
1999 1
2000 3
2001 5
2002 4
2003 1
2004 2
2005 5
2006 2
2007 3
2008 6
2009 5
2010 1
2011 3
2012 6
2013 5
2014 3
2015 6
2016 9
2017 7
2018 4
2019 8
2020 8
2021 7
2022 4
2023 2

Text availability

Article attribute

Article type

Publication date

Search Results

116 results

Results by year

Filters applied: . Clear all
Page 1
Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS.
Miller TM, Cudkowicz ME, Genge A, Shaw PJ, Sobue G, Bucelli RC, Chiò A, Van Damme P, Ludolph AC, Glass JD, Andrews JA, Babu S, Benatar M, McDermott CJ, Cochrane T, Chary S, Chew S, Zhu H, Wu F, Nestorov I, Graham D, Sun P, McNeill M, Fanning L, Ferguson TA, Fradette S; VALOR and OLE Working Group. Miller TM, et al. Among authors: fanning l. N Engl J Med. 2022 Sep 22;387(12):1099-1110. doi: 10.1056/NEJMoa2204705. N Engl J Med. 2022. PMID: 36129998 Free article. Clinical Trial.
Phase 1-2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS.
Miller T, Cudkowicz M, Shaw PJ, Andersen PM, Atassi N, Bucelli RC, Genge A, Glass J, Ladha S, Ludolph AL, Maragakis NJ, McDermott CJ, Pestronk A, Ravits J, Salachas F, Trudell R, Van Damme P, Zinman L, Bennett CF, Lane R, Sandrock A, Runz H, Graham D, Houshyar H, McCampbell A, Nestorov I, Chang I, McNeill M, Fanning L, Fradette S, Ferguson TA. Miller T, et al. Among authors: fanning l. N Engl J Med. 2020 Jul 9;383(2):109-119. doi: 10.1056/NEJMoa2003715. N Engl J Med. 2020. PMID: 32640130 Free article. Clinical Trial.
Author Reply.
Fanning L, Woods E, Hornung CJ, Perrett KP, Tang MLK, Dalziel K. Fanning L, et al. Value Health. 2022 Aug;25(8):1460-1462. doi: 10.1016/j.jval.2022.01.019. Epub 2022 Mar 12. Value Health. 2022. PMID: 35292193 No abstract available.
Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study.
Benatar M, Wuu J, Andersen PM, Bucelli RC, Andrews JA, Otto M, Farahany NA, Harrington EA, Chen W, Mitchell AA, Ferguson T, Chew S, Gedney L, Oakley S, Heo J, Chary S, Fanning L, Graham D, Sun P, Liu Y, Wong J, Fradette S. Benatar M, et al. Among authors: fanning l. Neurotherapeutics. 2022 Jul;19(4):1248-1258. doi: 10.1007/s13311-022-01237-4. Epub 2022 May 18. Neurotherapeutics. 2022. PMID: 35585374 Free PMC article. Clinical Trial.
Lipid mediators and allergic diseases.
Fanning LB, Boyce JA. Fanning LB, et al. Ann Allergy Asthma Immunol. 2013 Sep;111(3):155-62. doi: 10.1016/j.anai.2013.06.031. Epub 2013 Jul 21. Ann Allergy Asthma Immunol. 2013. PMID: 23987187 Free PMC article. Review.
Development of the immunoglobulin repertoire.
Fanning LJ, Connor AM, Wu GE. Fanning LJ, et al. Clin Immunol Immunopathol. 1996 Apr;79(1):1-14. doi: 10.1006/clin.1996.0044. Clin Immunol Immunopathol. 1996. PMID: 8612345 Review.
p38δ MAPK: Emerging Roles of a Neglected Isoform.
O'Callaghan C, Fanning LJ, Barry OP. O'Callaghan C, et al. Among authors: fanning lj. Int J Cell Biol. 2014;2014:272689. doi: 10.1155/2014/272689. Epub 2014 Sep 17. Int J Cell Biol. 2014. PMID: 25313309 Free PMC article. Review.
In vitro replication models for the hepatitis C virus.
Sheehy P, Mullan B, Moreau I, Kenny-Walsh E, Shanahan F, Scallan M, Fanning LJ. Sheehy P, et al. Among authors: fanning lj. J Viral Hepat. 2007 Jan;14(1):2-10. doi: 10.1111/j.1365-2893.2006.00807.x. J Viral Hepat. 2007. PMID: 17212638 Review.
Kemp Eliminase Activity of Ketosteroid Isomerase.
Lamba V, Sanchez E, Fanning LR, Howe K, Alvarez MA, Herschlag D, Forconi M. Lamba V, et al. Among authors: fanning lr. Biochemistry. 2017 Jan 31;56(4):582-591. doi: 10.1021/acs.biochem.6b00762. Epub 2017 Jan 20. Biochemistry. 2017. PMID: 28045505 Free PMC article.
116 results